Sugar-free Oreos launching in 2026. Here's how to get the new snack.

Mondelēz will roll out Oreo Zero Sugar Cookies nationwide in January 2026 (Original and Double Stuf), with the offering to be permanent and available early on the Oreo website at about $5.29 for a 20‑cookie bag. The product, developed over roughly four years, is sweetened with maltitol, polydextrose, sucralose and Ace‑K (no aspartame) and clocks in at roughly 45 calories per cookie versus about 53 for a regular Oreo. The launch represents a strategic extension into the sugar‑free/health‑conscious segment, broadening Mondelēz’s portfolio with a premium, reduced‑sugar indulgence aimed at capturing demand from consumers seeking lower‑sugar alternatives.

Analysis

Mondelēz announced on Dec. 9 that it will launch Oreo Zero Sugar Cookies nationwide in January 2026, offering Original and Double Stuf formulations with "Zero Sugar" stamped into the cookies; the company says the product will be a permanent SKU and will be available early on the Oreo website at $5.29 per 20-cookie bag after roughly four years of development. The company specifies the sugar-free formulation uses maltitol, polydextrose, sucralose and Ace-K and explicitly does not contain aspartame, positioning the product on ingredient perceptions as well as reduced sugar content.

Nutritionally, Mondelēz reports the sugar-free Oreo contains about 45 calories per cookie versus approximately 53 calories for a regular Oreo, creating a modest calorie differential that supports marketing to lower-sugar or calorie-conscious consumers. The product launch is classified under Product Launches and Consumer Demand & Retail themes and signals a strategic extension into the sugar-free/health-conscious segment rather than a core portfolio shift.

Market signals attached to the report are muted (sentiment_score 0.05, market_impact_score 0.08) with per-ticker sentiment modestly positive for MDLZ (0.4), suggesting limited immediate equity impact. Key near-term indicators to watch are early online sell-through, retail distribution depth and pricing acceptance; consumer taste and repeat purchase behavior remain the primary execution risks despite extended R&D.

Key Decisions for Investors

• Consider a measured overweight to MDLZ on product diversification potential, but size positions modestly until Jan-Feb 2026 sell-through and retail placement data are available
• Monitor early online sales velocity and initial retail shelf placements as primary leading indicators; increase exposure if repeat-purchase signals and distribution gains are evident
• Avoid speculative trading ahead of the rollout given the neutral market-impact signal; consider hedging catalysts around initial sales reports and promotional windows